A novel fully-automated method to measure steroids in serum by liquid chromatography-tandem mass spectrometry.

11DF, 11-deoxycortisol 17OHP, 17-hydroxyprogesterone 2D-UHPLC-MS/MS, Two dimensional ultra-high performance liquid chromatography-tandem mass spectrometry Automation D4, delta4-androstenedione DHEA, dehydroepiandrosterone EMA, European Medicine Agency GC–MS/MS, Gas chromatography tandem mass spectrometry LC-MS/MS, Liquid chromatography tandem mass spectrometry LLE, Liquid-liquid extraction LLOQ, Lower limit of quantification Liquid chromatography tandem mass spectrometry MRM, Multiple reaction monitoring PTFE, Polytetrafluoroethylene QC, Quality control RIA, Radioimmunoassay Radioimmunoassay SLE, Supported liquid extraction SPE, Solid phase extraction SRM, Standard reference material Steroids T, Testosterone Testosterone UHPLC, Ultra-high performance liquid chromatography

Journal

Journal of mass spectrometry and advances in the clinical lab
ISSN: 2667-145X
Titre abrégé: J Mass Spectrom Adv Clin Lab
Pays: Netherlands
ID NLM: 101776811

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 29 03 2022
revised: 24 11 2022
accepted: 12 12 2022
entrez: 3 1 2023
pubmed: 4 1 2023
medline: 4 1 2023
Statut: epublish

Résumé

Steroids play a key role in numerous physiological processes. Steroid determination is a useful tool to explore various endocrine diseases. Because of its specificity, mass spectrometry is considered to be a reference method for the determination of steroids in serum compared to radioimmunoassay. This technology could progress towards more automation for the optimal organization of clinical laboratories and ultimately for the benefit of patients. A fully automated ultra-high-performance liquid chromatography-tandem mass spectrometry method was developed and fully validated to determine five steroids in serum. Sample preparation was based on protein precipitation with filtration followed by online solid phase extraction. Chromatographic separation was performed using a biphenyl stationary phase. The method was successfully validated according to European Medicine Agency guidelines. Coefficients of variation did not exceed, respectively, 8.4% and 8.1% for intra- and inter-assay precision. Method comparison with radioimmunoassay showed a proportional bias for all compounds, except for testosterone in men. Comparison with another LC-MS/MS method demonstrated acceptable concordance for all steroids, although a small bias was observed for androstenedione. The novelty of this method is that it has been fully automated. Automation provides benefits in traceability and allows significant savings in cost and time.

Sections du résumé

Background UNASSIGNED
Steroids play a key role in numerous physiological processes. Steroid determination is a useful tool to explore various endocrine diseases. Because of its specificity, mass spectrometry is considered to be a reference method for the determination of steroids in serum compared to radioimmunoassay. This technology could progress towards more automation for the optimal organization of clinical laboratories and ultimately for the benefit of patients.
Methods UNASSIGNED
A fully automated ultra-high-performance liquid chromatography-tandem mass spectrometry method was developed and fully validated to determine five steroids in serum. Sample preparation was based on protein precipitation with filtration followed by online solid phase extraction. Chromatographic separation was performed using a biphenyl stationary phase.
Results UNASSIGNED
The method was successfully validated according to European Medicine Agency guidelines. Coefficients of variation did not exceed, respectively, 8.4% and 8.1% for intra- and inter-assay precision. Method comparison with radioimmunoassay showed a proportional bias for all compounds, except for testosterone in men. Comparison with another LC-MS/MS method demonstrated acceptable concordance for all steroids, although a small bias was observed for androstenedione.
Conclusion UNASSIGNED
The novelty of this method is that it has been fully automated. Automation provides benefits in traceability and allows significant savings in cost and time.

Identifiants

pubmed: 36593910
doi: 10.1016/j.jmsacl.2022.12.004
pii: S2667-145X(22)00046-3
pmc: PMC9804132
doi:

Types de publication

Journal Article

Langues

eng

Pagination

24-32

Informations de copyright

© 2022 THE AUTHORS.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Clin Biochem. 2019 Jun;68:37-43
pubmed: 30928392
Clin Chem. 2016 Jan;62(1):24-9
pubmed: 26430075
Clin Chem. 2013 Feb;59(2):372-80
pubmed: 23213081
Clin Mass Spectrom. 2020 Jan 23;16:1-10
pubmed: 34820514
J Chromatogr A. 2017 Dec 1;1526:112-118
pubmed: 29061472
Clin Mass Spectrom. 2019 Jan 06;11:42-51
pubmed: 34841072
Clin Chem. 2020 Sep 1;66(9):1150-1154
pubmed: 32870997
J Chromatogr A. 2007 Jun 22;1154(1-2):138-51
pubmed: 17462664
J Pharm Biomed Anal. 2017 Aug 5;142:66-73
pubmed: 28499151
Steroids. 2011 Feb;76(3):244-53
pubmed: 21112348
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):202-211
pubmed: 27339652
Clin Chem. 1988 Oct;34(10):2070-5
pubmed: 2971475
J Steroid Biochem. 1977 Sep;8(9):995-1009
pubmed: 199798
Clin Chem. 2010 Jul;56(7):1138-47
pubmed: 20489135
Clin Chim Acta. 2015 Oct 23;450:298-303
pubmed: 26341893
Clin Chim Acta. 2013 Jan 16;415:109-17
pubmed: 23085208
Clin Chem Lab Med. 2020 Feb 21;58(9):1477-1487
pubmed: 32084000
Anal Bioanal Chem. 2018 Aug;410(20):5071-5083
pubmed: 29947899
J Pharm Biomed Anal. 2014 Jan;87:120-9
pubmed: 23746991
Clin Chim Acta. 2016 Feb 15;454:112-8
pubmed: 26778410
J Anal Toxicol. 2021 Mar 12;45(3):252-268
pubmed: 32596736
J Endocr Soc. 2017 Feb 10;1(3):186-201
pubmed: 29264476
Clin Chem Lab Med. 2020 Jun 25;58(6):994-1001
pubmed: 32191622
Sci Rep. 2021 Aug 6;11(1):16023
pubmed: 34362961
Clin Biochem. 2017 Dec;50(18):1260-1274
pubmed: 28733189
J Chromatogr A. 2016 Sep 16;1464:64-71
pubmed: 27554022
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Apr 1;1142:122038
pubmed: 32169798
Clin Chem Lab Med. 2016 Sep 1;54(9):1451-9
pubmed: 26872314
Anal Biochem. 2017 Dec 1;538:34-37
pubmed: 28887174
BMC Clin Pathol. 2014 Jul 14;14:33
pubmed: 25071417

Auteurs

François Fraissinet (F)

Department of General Biochemistry, Rouen University Hospital, 76000 Rouen, France.

Tony Pereira (T)

Department of General Biochemistry, Rouen University Hospital, 76000 Rouen, France.

Alizée Violin (A)

Nantes Université, CHU Nantes, Department of Biology, Laboratory of Biochemistry, F-44000 Nantes, France.

Guillaume Feugray (G)

Department of General Biochemistry, Rouen University Hospital, 76000 Rouen, France.
Normandie University, UNIROUEN, INSERM U1096 Rouen, France.

Kalyane Bach-Ngohou (K)

Nantes Université, CHU Nantes, Department of Biology, Laboratory of Biochemistry, F-44000 Nantes, France.
Nantes Université, CHU Nantes, INSERM, The Enteric Nervous System in Gut and Brain Disorders, IMAD, F-44000 Nantes, France.

Valéry Brunel (V)

Department of General Biochemistry, Rouen University Hospital, 76000 Rouen, France.

Classifications MeSH